ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIIB Biogen Inc

221.58
0.00 (0.00%)
Pre Market
Last Updated: 11:22:45
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biogen Inc NASDAQ:BIIB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 221.58 222.01 223.25 44 11:22:45

Biogen Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BIIB

16/07/2024 9:00am

PR Newswire (US)


Biogen (NASDAQ:BIIB)
Intraday Stock Chart


Tuesday 16 July 2024

Click Here for more Biogen Charts.

LOS ANGELES, July 16, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ:BIIB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

DJS Law Group

Shareholders who purchased shares of BIIB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 3, 2022 to February 13, 2024

DEADLINE: July 22, 2024

CASE DETAILS: The investigation focuses on whether the Company made false and misleading statements to the market. Biogen overstated its efforts to enhance controls and procedures. The Company failed to maintain adequate controls especially in business operations in foreign countries. The Company's employees were engaging in illegal behaviors in certain foreign markets. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Biogen, investors suffered damages.

If you are a shareholder who suffered a loss, please contact David Schwartz, Esq., at 914-206-9742, or by email at David@djslawllp.com

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
 Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biogen-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights---biib-302197646.html

SOURCE DJS Law Group LLP

Copyright 2024 PR Newswire

1 Year Biogen Chart

1 Year Biogen Chart

1 Month Biogen Chart

1 Month Biogen Chart